NORTHERN BIOLOGICS INC.
Northern Biologics use state-of-the-art antibody discovery to tackle novel and challenging targets in oncology and fibrosis. Its therapeutic antibody candidates are derived from a state-of-the-art phage display platform developed and refined by world-leading researchers at the University of Toronto, and we focus on developing novel functional modulators of key signaling pathways in cancer and fibrosis. Northern Biologics was founded in 2014 and headquartered in Toronto, Ontario, Canada.
NORTHERN BIOLOGICS INC.
Social Links:
Industry:
Biotechnology Health Care
Founded:
2014-01-01
Address:
Toronto, Ontario, Canada
Country:
Canada
Website Url:
http://www.northernbiologics.com
Total Employee:
11+
Status:
Closed
Contact:
(416)634-7132
Email Addresses:
[email protected]
Total Funding:
7.29 M USD
Technology used in webpage:
SPF LetsEncrypt Apache Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS CPanel SSL Oracle Cloud NSONE
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2016-12-01 | Mosaic Biomedicals | Mosaic Biomedicals acquired by Northern Biologics Inc. | N/A |
Investors List
Sixty Degree Capital
Sixty Degree Capital investment in Venture Round - Northern Biologics Inc.
Official Site Inspections
http://www.northernbiologics.com
- Host name: 39.240.198.66.in-addr.arpa
- IP address: 66.198.240.39
- Location: Ann Arbor United States
- Latitude: 42.2503
- Longitude: -83.8393
- Metro Code: 505
- Timezone: America/Detroit
- Postal: 48106
More informations about "Northern Biologics Inc."
Northern Biologics Inc. - Crunchbase Company Profile & Funding
Northern Biologics use state-of-the-art antibody discovery to tackle novel and challenging targets in oncology and fibrosis. Its therapeutic antibody candidates are derived from a state-of-the-art …See details»
BI Expands Immuno-oncology Portfolio | Boehringer Ingelheim US
Ingelheim, Germany and Toronto, Canada – 14 May 2020 – Boehringer Ingelheim today announced the acquisition of Northern Biologics Inc., a wholly owned subsidiary of Northern …See details»
Northern Biologics Company Profile 2024: Valuation, …
Northern Biologics is headquartered in Toronto, Canada. What is the size of Northern Biologics? Northern Biologics has 21 total employees. What industry is Northern Biologics in? Northern Biologics’s primary industry is Drug …See details»
Northern Biologics Company Overview, Contact Details
Northern Biologics 's official website is northernbiologics.com and has social profiles on LinkedIn. What is Northern Biologics 's SIC code NAICS code ? Northern Biologics 's SIC code is 8733 - …See details»
Northern Biologics - Versant Ventures
In early 2018, Northern Biologics will begin clinical testing of its lead immuno-oncology asset, MSC-1, in a range of cancers, working with world-leading cancer institutes in Canada, Europe and the U.S. MSC-1 is a humanized antibody …See details»
Northern Biologics Inc Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Northern Biologics Inc of Toronto, ON. Get the latest business insights from Dun & Bradstreet.See details»
Northern Biologics - Ownership and Business Overview - Mergr
Northern Biologics was established in 2014 and is based in Toronto, Ontario. Company Summary. SECTOR. Life Science. Established. 2014. Investor History; 2020-05-14 Add-on Acquisition. …See details»
Northern Biologics - VentureRadar
Northern Biologics is a clinical stage company launched in Toronto in late 2014 with a vision to discover, develop and advance first-in-class antibody therapeutics to improve patient …See details»
Northern Biologics Inc. acquired by Boehringer Ingelheim
May 14, 2020 Northern Biologics Inc. Northern Biologics use state-of-the-art antibody discovery to tackle novel and challenging targets in oncology and fibrosis. Acquiring Organization: …See details»
Northern Biologics Company Profile - Office Locations ... - Craft
Northern Biologics is a biotechnology company. It offers therapeutic antibodies modifying the tumor microenvironment in targeted patient populations. The company provides MSC-1, an …See details»
Boehringer Ingelheim acquires Northern Biologics to expand …
May 18, 2020 The Northern Biologics-Boehringer Ingelheim acquisition represents the second recent transaction for a Versant-built company operating out of the MaRS discovery district in …See details»
Boehringer Ingelheim Acquires Northern Biologics’ Preclinical …
May 14, 2020 The Northern Biologics-Boehringer Ingelheim acquisition represents the second recent transaction for a Versant-built company operating out of the MaRS discovery district in …See details»
Northern Biologics Start-up - UHN Research
Northern Biologics is the first spin-out company from Blueline Biosciences, a Canadian biotechnology incubator backed by Versant Ventures. It was developed using a “build-to-buy” …See details»
Northern Biologics - Overview, News & Similar companies
Oct 29, 2019 Northern Biologics Reports Phase I Data Update for MSC-1, an Anti-LIF Antibody, at ESMO TORONTO & BOSTON--(BUSINESS WIRE)--Northern Biologics Inc., a …See details»
Boehringer Ingelheim acquires Canada's Northern Biologics
May 14, 2020 Boehringer Ingelheim Corp. acquired Toronto-based Northern Biologics Inc., including its cancer programs aimed at developing antibodies for the tumor microenvironment. …See details»
Boehringer Ingelheim acquires Northern Biologics to expand …
May 18, 2020 Northern Biologics retains rights to its lead asset, MSC-1, an anti-LIF 1 antibody that recently successfully completed Phase 1 clinical trials. The Northern Biologics-Boehringer …See details»
Interview: Stefan Larson – CEO, Northern Biologics, Canada
Nov 16, 2017 Northern Biologics works in the area of immuno-oncology, which is one of the hottest areas within the industry today. What differentiates Northern Biologics from other …See details»
Northern Biologics: new biotech company to develop cancer drugs
“Antibodies and other medical products from biological sources play an expanding, revolutionary role as alternatives to small molecule drugs by treating disease in a more targeted way and …See details»
Northern Biologics Strengthens Management Team - Business Wire
Aug 1, 2018 Northern Biologics Inc., a developer of first-in-class immuno-oncology products, today announced the appointment of Enda Moran, Ph.D., MBA, as vice pr Northern Biologics …See details»
Northern Biologics - VentureRadar
" Northern Biologics is a clinical stage company launched in Toronto in late 2014 with a vision to discover, develop and advance first-in-class antibody therapeutics to improve patient …See details»